Skip to main content

Peer Review reports

From: Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Original Submission
9 Feb 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
14 Jun 2016 Editorially accepted
19 Jul 2016 Article published 10.1186/s12883-016-0629-9

You can find further information about peer review here.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us